Bolt Biotherapeutics, Inc.
At Close: 4:00 PM
BOLT Stock Price Graph
BOLT Stock Price Today
Bolt Biotherapeutics, Inc. (BOLT) stock declined over -0.97% intraday to trade at $0.921 a share on NASDAQ. The stock opened with a gain of 2.41% at $0.95 and touched an intraday high of $1.00, falling -0.97% against the last close of $0.93. The Bolt Biotherapeutics, Inc. in stock market went to a low of $0.95 during the session.
BOLT Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BOLT Stock Price History Chart
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.
Frequently Asked Questions
What is the current Bolt Biotherapeutics, Inc. (BOLT) stock price?
Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) stock price is $0.92 in the last trading session. During the trading session, BOLT stock reached the peak price of $1.00 while $0.95 was the lowest point it dropped to. The percentage change in BOLT stock occurred in the recent session was -0.97% while the dollar amount for the price change in BOLT stock was -$0.01.
BOLT's industry and sector of operation?
The NASDAQ listed BOLT is part of Biotechnology industry that operates in the broader Healthcare sector. Bolt Biotherapeutics, Inc. , a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system.
Who are the executives of BOLT?
Mr. Bruce Hug M.D., Ph.D.
Senior Vice President of Clinical Devel. & Translational Medicine
Dr. Ming Yin Ph.D.
Vice President & Head of Biometrics
Mr. Wesley Burwell
Vice President & Head of HR
Dr. Randall C. Schatzman Ph.D.
Chief Executive Officer & Director
How BOLT did perform over past 52-week?
BOLT's closing price is 0.30% higher than its 52-week low of $0.891 where as its distance from 52-week high of $2.03 is -0.44%.
How many employees does BOLT have?
Number of BOLT employees currently stands at N/A. BOLT operates from 900 Chesapeake Drive, Redwood City, CA 94063, US.
Link for BOLT official website?
Official Website of BOLT is: https://www.boltbio.com
How do I contact BOLT?
How many shares of BOLT are traded daily?
BOLT stock volume for the day was 11798.00 shares. The average number of BOLT shares traded daily for last 3 months was 112.74 Thousands.
What is the market cap of BOLT currently?
The market value of BOLT currently stands at $34.97 Million with its latest stock price at $0.92 and N/A of its shares outstanding.